DK378188A - Alkenderivater - Google Patents

Alkenderivater

Info

Publication number
DK378188A
DK378188A DK378188A DK378188A DK378188A DK 378188 A DK378188 A DK 378188A DK 378188 A DK378188 A DK 378188A DK 378188 A DK378188 A DK 378188A DK 378188 A DK378188 A DK 378188A
Authority
DK
Denmark
Prior art keywords
lower alkyl
aryl
hydrogen
independently
het
Prior art date
Application number
DK378188A
Other languages
English (en)
Other versions
DK378188D0 (da
Inventor
Robert William Guthrie
Richard Wightman Kierstad
Jefferson Wright Tilley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK378188D0 publication Critical patent/DK378188D0/da
Publication of DK378188A publication Critical patent/DK378188A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK378188A 1987-07-10 1988-07-07 Alkenderivater DK378188A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/072,389 US4788206A (en) 1987-07-10 1987-07-10 Pentadieneamides

Publications (2)

Publication Number Publication Date
DK378188D0 DK378188D0 (da) 1988-07-07
DK378188A true DK378188A (da) 1989-01-11

Family

ID=22107243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK378188A DK378188A (da) 1987-07-10 1988-07-07 Alkenderivater

Country Status (21)

Country Link
US (1) US4788206A (da)
EP (1) EP0299379B1 (da)
JP (1) JPS6431766A (da)
KR (1) KR890001989A (da)
AT (1) ATE88466T1 (da)
AU (1) AU626526B2 (da)
CZ (1) CZ394991A3 (da)
DE (1) DE3880387D1 (da)
DK (1) DK378188A (da)
ES (1) ES2054740T3 (da)
FI (1) FI883290A (da)
HU (1) HU205902B (da)
IL (1) IL87017A0 (da)
MC (1) MC1954A1 (da)
MX (1) MX9203599A (da)
NO (1) NO883084L (da)
NZ (1) NZ225327A (da)
PH (1) PH24605A (da)
PT (1) PT87953B (da)
YU (1) YU46716B (da)
ZA (1) ZA884857B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298466A3 (en) * 1987-07-10 1990-10-24 F. Hoffmann-La Roche Ag Substituted alkene carboxylic acid amides and derivatives
US5369106A (en) * 1989-04-28 1994-11-29 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists
US5192766A (en) * 1989-04-28 1993-03-09 Sankyo Company, Limited N-acryloylpiperazine derivatives, their preparation and their use as PAF antagonists
KR100568997B1 (ko) * 1996-04-23 2006-12-15 타가셉트 인코포레이티드 중추신경계질환의예방및치료를위한약제학적조성물
JP4357001B2 (ja) * 1996-04-23 2009-11-04 ターガセプト,インコーポレイテッド 中枢神経系障害の予防及び治療のための医薬組成物
WO1997043241A1 (fr) * 1996-05-13 1997-11-20 Nippon Shinyaku Co., Ltd. Composes d'ethylene substitue et medicaments
HUP0100860A3 (en) * 1997-12-11 2003-03-28 Janssen Pharmaceutica Nv Retinoic acid mimetic anilides, process for their preparation and pharmaceutical compositions containing them
US6232316B1 (en) 1998-06-16 2001-05-15 Targacept, Inc. Methods for treatment of CNS disorders
DE19828463A1 (de) * 1998-06-26 1999-12-30 Basf Ag 4,4-Diarylbutadiene als wasserlösliche photostabile UV-Filter für kosmetische und pharmazeutische Zubereitungen
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
WO2000075110A1 (en) * 1999-06-07 2000-12-14 Targacept, Inc. Pharmaceutical compositions and methods for use
CA2476936A1 (en) * 2002-02-20 2003-08-28 Chih-Hung Lee Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
BRPI0408005A (pt) * 2003-03-05 2006-02-14 Celgene Corp composto, composição farmacêutica, métodos para inibir angiogênese, atividade de pde4 em uma célula e proliferação de célula de cáncer, para inibir ou reduzir polimerização de tubulina ou estabilidade de tubulina em uma célula, para tratar ou melhorar um distúrbio inflamatório, um cáncer e um distúrbio do sistema nervoso central e para visar, bloquear ou destruir a função de vasculatura de tumor e o endotélio de vasos de tumor
KR20070083484A (ko) * 2004-07-14 2007-08-24 피티씨 테라퓨틱스, 인크. C형 간염 치료 방법
US7772271B2 (en) * 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) * 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7781478B2 (en) * 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
NZ553329A (en) * 2004-07-22 2010-09-30 Ptc Therapeutics Inc Thienopyridines for treating hepatitis C
WO2008007780A1 (fr) 2006-07-13 2008-01-17 Kyowa Hakko Kirin Co., Ltd. Dérivé du pentadiènamide
TW200824687A (en) 2006-08-25 2008-06-16 Abbott Lab Compounds that inhibit TRPV1 and uses thereof
MX2011001887A (es) 2008-08-22 2011-04-04 Baxter Int Derivados de bencil carbonato polimericos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072649A (en) * 1963-01-08 S-tmalkoxycinnamamide derivatives
US4568687A (en) * 1983-02-28 1986-02-04 American Cyanamid Company N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
US4568685A (en) * 1984-02-29 1986-02-04 American Cyanamid Company N-[(1H-1,2,4-Triazol-1-yl)alkyl]-arylamides
US4542145A (en) * 1984-02-29 1985-09-17 American Cyanamid Company Substituted N-[(1H-1,2,4-triazol-1-yl)-alkyl]heteroarylcarboxamides
US4673684A (en) * 1984-04-04 1987-06-16 Terumo Corporation Amide derivatives and 5-lipoxygenase inhibitors containing the same as an active ingredient
JPS6144869A (ja) * 1984-08-10 1986-03-04 Terumo Corp イミダゾ−ル誘導体およびこれを含有する血小板凝集抑制剤
JPS6144870A (ja) * 1984-08-10 1986-03-04 Terumo Corp 不飽和脂肪酸アミド誘導体およびこれを含有する血小板凝集抑制剤
JPS6212757A (ja) * 1985-07-10 1987-01-21 Yoshitomi Pharmaceut Ind Ltd 桂皮酸アミド誘導体
US4778796A (en) * 1985-07-19 1988-10-18 Dainippon Pharmaceutical Co., Ltd. ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same
JPH06144869A (ja) * 1992-11-10 1994-05-24 Matsunami Glass Kogyo Kk バイオ担体用多孔質ガラス

Also Published As

Publication number Publication date
IL87017A0 (en) 1988-12-30
ES2054740T3 (es) 1994-08-16
MC1954A1 (fr) 1989-06-30
HUT48594A (en) 1989-06-28
NZ225327A (en) 1991-08-27
PT87953B (pt) 1995-03-01
YU46716B (sh) 1994-04-05
DE3880387D1 (de) 1993-05-27
NO883084D0 (no) 1988-07-08
ZA884857B (en) 1989-04-26
AU626526B2 (en) 1992-08-06
PT87953A (pt) 1989-06-30
KR890001989A (ko) 1989-04-07
PH24605A (en) 1990-08-17
AU1885188A (en) 1989-01-12
EP0299379A1 (de) 1989-01-18
CZ394991A3 (en) 1993-01-13
DK378188D0 (da) 1988-07-07
HU205902B (en) 1992-07-28
MX9203599A (es) 1992-07-01
EP0299379B1 (de) 1993-04-21
JPS6431766A (en) 1989-02-02
US4788206A (en) 1988-11-29
FI883290A (fi) 1989-01-11
ATE88466T1 (de) 1993-05-15
FI883290A0 (fi) 1988-07-08
YU132488A (en) 1991-02-28
NO883084L (no) 1989-01-11

Similar Documents

Publication Publication Date Title
DK378188A (da) Alkenderivater
FI904460A0 (fi) Isoxazol-herbicider.
BG60030B2 (bg) Метод за получаване на (d)-алфа-етил-2-оксо-1- пиролидинацетамид
DZ863A1 (fr) Dérivés de benzoxazol et benzothiazolamine.
NO892058D0 (no) Fremgangsnaate for fremstilling av terapeutisk aktive benzamider.
IL70528A (en) Pharmaceutical compositions comprising derivatives of naphthalene-or azanaphthalenecarboxamide,novel derivatives of such compounds and processes for their preparation
FI861562A (fi) Substituerade n-/(4-piperidinyl) alkyl/-bicykliska kondenserade oxazol- och tiazolaminer.
DE69202166D1 (de) Verwendung von Tetrahydrothienopyridinderivate als Angiogenese-Inhibitoren.
EP0298466A3 (en) Substituted alkene carboxylic acid amides and derivatives
IL96762A0 (en) Pyridyl cyclopropane derivatives,process for their preparation and fungicidal compositions containing them
DE69012653D1 (de) Heterocyclische Triazin- oder Triazolo-Verbindungen mit Serotonin 2-Rezeptor-Antagonisten-Wirkung.
EP0309425A3 (en) New heterocyclic derivatives
SE8800171D0 (sv) Nya 5-oxi-derivat av tetrahydrofuran
JPS54128588A (en) Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
NO169773C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,5-benzoksatiepinderivater
SE8800846D0 (sv) Optiskt aktiva oxo-isoindolinderivat
TH14924EX (th) อนุพันธ์ต่าง ๆ ของไทรอะโซลที่ฆ่าเชื้อราการเตรียมและการใช้ต่าง ๆ ของสารเหล่านี้

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment